Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
7.52
-0.25 (-3.22%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Q32 Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 33.79 | 29.82 | -47.73 | -53.74 | -42.81 | -37.56 |
Depreciation & Amortization | 0.36 | 0.39 | 0.49 | 0.5 | 0.37 | 0.05 |
Other Amortization | 0.18 | 0.18 | 0.19 | 0.09 | 0.1 | 0.1 |
Loss (Gain) From Sale of Assets | -11.74 | -11.74 | - | - | 0.02 | - |
Loss (Gain) From Sale of Investments | - | 0.07 | 0.45 | - | - | - |
Loss (Gain) on Equity Investments | - | - | 1.63 | - | - | - |
Stock-Based Compensation | 5.88 | 5.26 | 4.39 | 1.43 | 1.24 | 0.75 |
Other Operating Activities | -53.08 | -53.49 | -17.49 | 6.74 | 3.18 | - |
Change in Accounts Payable | 0.66 | -2.11 | -1.04 | 2.03 | -1.24 | 1.1 |
Change in Unearned Revenue | - | - | - | -25.85 | 25.85 | - |
Change in Other Net Operating Assets | 4.13 | -1.93 | -8.59 | 50.13 | 2.34 | 2.58 |
Operating Cash Flow | -19.83 | -33.54 | -67.72 | -18.68 | -10.96 | -32.98 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | -0.08 | -0.01 | -2.49 | -0.16 |
Sale of Property, Plant & Equipment | 7 | 7 | - | - | 0.02 | - |
Investment in Securities | - | - | 20 | - | - | - |
Investing Cash Flow | 7 | 7 | 19.93 | -0.01 | -2.47 | -0.16 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | 7 | 5.5 | 30 | - |
Long-Term Debt Repaid | - | -3.13 | - | -5.2 | - | - |
Net Debt Issued (Repaid) | -12.95 | -3.13 | 7 | 0.3 | 30 | - |
Issuance of Common Stock | 77.21 | - | 43.69 | 0.11 | 0.07 | 0.12 |
Other Financing Activities | - | - | 44.44 | - | - | - |
Financing Cash Flow | 64.27 | -3.13 | 95.14 | 0.41 | 30.07 | 20.11 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 51.44 | -29.67 | 47.35 | -18.28 | 16.65 | -13.03 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -19.83 | -33.54 | -67.79 | -18.68 | -13.44 | -33.14 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -36.90% | -62.42% | - | - | -202.10% | - |
Free Cash Flow Per Share | -1.33 | -2.72 | -7.02 | -53.52 | -1.91 | -5.12 |
Levered Free Cash Flow | 19.39 | 4.52 | -37.95 | -41.84 | -8.73 | - |
Unlevered Free Cash Flow | 19.77 | 5.03 | -37.27 | -40.68 | -8.83 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.86 | 0.96 | 0.86 | - | - | - |
Change in Working Capital | 4.78 | -4.04 | -9.64 | 26.32 | 26.94 | 3.68 |